Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
4261.10%
↑ 3856% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
107.71%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 4261.10% |
| Q3 2025 | -49.97% |
| Q2 2025 | 26.14% |
| Q1 2025 | -2.14% |
| Q4 2024 | -2.14% |
| Q3 2024 | -1.58% |
| Q2 2024 | -1.49% |
| Q1 2024 | -2.08% |
| Q4 2023 | -2.08% |
| Q3 2023 | -1.94% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | -2.03% |
| Q3 2022 | -1.99% |
| Q2 2022 | -1.97% |
| Q1 2022 | -1.98% |
| Q4 2021 | -1.97% |
| Q3 2021 | -2.60% |
| Q2 2021 | -2.69% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |